Does WARFARIN Cause Product dose omission issue? 76 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 76 reports of Product dose omission issue have been filed in association with WARFARIN (Warfarin Sodium). This represents 0.2% of all adverse event reports for WARFARIN.
76
Reports of Product dose omission issue with WARFARIN
0.2%
of all WARFARIN reports
23
Deaths
55
Hospitalizations
How Dangerous Is Product dose omission issue From WARFARIN?
Of the 76 reports, 23 (30.3%) resulted in death, 55 (72.4%) required hospitalization, and 22 (28.9%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for WARFARIN. However, 76 reports have been filed with the FAERS database.
What Other Side Effects Does WARFARIN Cause?
International normalised ratio increased (5,622)
Haemorrhage (2,930)
Gastrointestinal haemorrhage (2,469)
Anaemia (2,409)
Drug interaction (2,056)
Fall (1,702)
Drug ineffective (1,658)
Epistaxis (1,498)
Contusion (1,467)
Dyspnoea (1,374)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)